190 related articles for article (PubMed ID: 34974204)
1. Progression to a severe form of COVID-19 among patients with chronic respiratory diseases.
Basin S; Valentin S; Maurac A; Poussel M; Pequignot B; Brindel A; Poupet G; Robert C; Baumann C; Luc A; Soler J; Chabot F; Chaouat A
Respir Med Res; 2022 May; 81():100880. PubMed ID: 34974204
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection.
Calmes D; Graff S; Maes N; Frix AN; Thys M; Bonhomme O; Berg J; Debruche M; Gester F; Henket M; Paulus V; Duysinx B; Heinen V; Dang DN; Paulus A; Quaedvlieg V; Vaillant F; Van Cauwenberge H; Malaise M; Gilbert A; Ghuysen A; Gillet P; Moutschen M; Misset B; Sibille A; Guiot J; Corhay JL; Louis R; Schleich F
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):160-169. PubMed ID: 33038592
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece.
Kyriakopoulos C; Gogali A; Exarchos K; Potonos D; Tatsis K; Apollonatou V; Loukides S; Papiris S; Sigala I; Katsaounou P; Aggelidis M; Fouka E; Porpodis K; Kontakiotis T; Sampsonas F; Karampitsakos T; Tzouvelekis A; Bibaki E; Karagiannis K; Antoniou K; Tzanakis N; Dimeas I; Daniil Z; Gourgoulianis K; Kouratzi M; Steiropoulos P; Antonakis E; Papanikolaou IC; Ntritsos G; Kostikas K
Respiration; 2021; 100(7):588-593. PubMed ID: 33827103
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
[TBL] [Abstract][Full Text] [Related]
6. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.
Chan KPF; Ma TF; Kwok WC; Leung JKC; Chiang KY; Ho JCM; Lam DCL; Tam TCC; Ip MSM; Ho PL
Respir Med; 2020 Sep; 171():106085. PubMed ID: 32917356
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection.
Brendish NJ; Poole S; Naidu VV; Mansbridge CT; Norton N; Borca F; Phan HT; Wheeler H; Harvey M; Presland L; Clark TW
J Infect; 2020 Dec; 81(6):937-943. PubMed ID: 32998038
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19.
Cornwell CR; Hsu J; Tompkins LK; Pennington AF; Flanders WD; Sircar K
J Asthma; 2022 Dec; 59(12):2509-2519. PubMed ID: 34902258
[TBL] [Abstract][Full Text] [Related]
9. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19.
Figueira-Gonçalves JM; García-Bello MÁ; Ramallo-Fariña Y; Méndez R; Latorre Campos A; González-Jiménez P; Peces-Barba G; Molina-Molina M; España PP; García E; Domínguez-Pazos SJ; García Clemente M; Panadero C; de la Rosa-Carrillo D; Sibila O; Martínez-Pitarch MD; Toledo-Pons N; López-Ramirez C; Almonte-Batista W; Macías-Paredes A; Badenes-Bonet D; Pérez-Rodas EN; Lázaro J; Quirós Fernández S; Cordovilla R; Cano-Pumarega I; Torres A; Menendez R;
Int J Chron Obstruct Pulmon Dis; 2023; 18():2473-2481. PubMed ID: 37955022
[TBL] [Abstract][Full Text] [Related]
10. [Exacerbation of obstructive pulmonary diseases by SARS-CoV-2 infection in patients treated in the Pulmonology Clinic of Târgu Mures].
Szathmáry M; Gîrbovan EC; Sárközi HK; Gáll Z; Vultur MA; Nemeș AF; Ianoși ES; Jimborean G
Orv Hetil; 2023 Jan; 164(2):43-50. PubMed ID: 36641756
[TBL] [Abstract][Full Text] [Related]
11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 in New South Wales children during 2021: severity and clinical spectrum.
Williams P; Koirala A; Saravanos GL; Lopez LK; Glover C; Sharma K; Williams T; Carey E; Shaw N; Dickens E; Sitaram N; Ging J; Bray P; Crawford NW; McMullan B; Macartney K; Wood N; Fulton EL; Lau C; Britton PN
Med J Aust; 2022 Sep; 217(6):303-310. PubMed ID: 35851698
[TBL] [Abstract][Full Text] [Related]
13. Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections.
So JY; O'Hara NN; Kenaa B; Williams JG; deBorja CL; Slejko JF; Zafari Z; Sokolow M; Zimand P; Deming M; Marx J; Pollak AN; Reed RM
Am J Med; 2021 Oct; 134(10):1252-1259.e3. PubMed ID: 34126098
[TBL] [Abstract][Full Text] [Related]
14. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
Gemicioglu B; Uzun H; Borekci S; Karaali R; Kurugoglu S; Atukeren P; Sirolu S; Durmus S; Dirican A; Kuskucu MA; Tabak F
J Infect Dev Ctries; 2021 Oct; 15(10):1415-1425. PubMed ID: 34780364
[TBL] [Abstract][Full Text] [Related]
15. Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort study.
Meng M; Wei R; Wu Y; Zeng R; Luo D; Ma Y; Zhang L; Huang W; Zeng H; Leung FW; Qiu X; Sha W; Chen H
EClinicalMedicine; 2024 Mar; 69():102500. PubMed ID: 38389713
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study.
Aabakke AJM; Krebs L; Petersen TG; Kjeldsen FS; Corn G; Wøjdemann K; Ibsen MH; Jonsdottir F; Rønneberg E; Andersen CS; Sundtoft I; Clausen T; Milbak J; Burmester L; Lindved B; Thorsen-Meyer A; Khalil MR; Henriksen B; Jønsson L; Andersen LLT; Karlsen KK; Pedersen ML; Klemmensen Å; Vestgaard M; Thisted D; Tatla MK; Andersen LS; Brülle AL; Gulbech A; Andersson CB; Farlie R; Hansen L; Hvidman L; Sørensen AN; Rathcke SL; Rubin KH; Petersen LK; Jørgensen JS; Stokholm L; Bliddal M
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2097-2110. PubMed ID: 34467518
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
18. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.
Gülsen A; König IR; Jappe U; Drömann D
Respirology; 2021 Jun; 26(6):552-565. PubMed ID: 33955623
[TBL] [Abstract][Full Text] [Related]
19. Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.
Valverde-Monge M; Cañas JA; Barroso B; Betancor D; Ortega-Martin L; Gómez-López A; Rodríguez-Nieto MJ; Mahíllo-Fernández I; Sastre J; Del Pozo V
Front Immunol; 2021; 12():668074. PubMed ID: 34149705
[TBL] [Abstract][Full Text] [Related]
20. Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease.
Mostafaei A; Ghojazadeh M; Hajebrahimi S; Abolhasanpour N; Salehi-Pourmehr H
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):140-146. PubMed ID: 33904672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
